WSD-1227

N/A

Report date: 2025/01/09 16:41:42
NME

Base Information

Drug NameWSD-1227
Drug Alias NameWSD-1227
ClassificationSmall molecules
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsBrain metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWayshine Biopharm International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWayshine Biopharm International Ltd
Inactive CompaniesN/A
Active IndicationsBrain metastases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A